Structural Basis for Unusual TCR CDR3β Usage Against an Immunodominant HIV-1 Gag Protein Peptide Restricted to an HLA-B*81:01 Molecule.

导出 LinkOut

翻译打印收藏纠错

作者： Yang,Liu ^[1] ; Jun,Lei ^[2] ; Dan,San ^[1] ; Yi,Yang ^[1] ; Chonil,Paek ^[1] ; Zixiong,Xia ^[1] ; Yongshun,Chen ^[2] ; Lei,Yin ^[1]

作者单位： State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China. ^[1] Department of Clinical Oncology, Renmin Hospital of Wuhan University, Wuhan, China. ^[2]

关键词 CD8+ T cells HIV HLA T cell receptor antigen presentation

主题词 CD8阳性T淋巴细胞(CD8-Positive T-Lymphocytes);HIV-1(HIV-1);HLA-B抗原(HLA-B Antigens);人类(Humans);免疫显性表位(Immunodominant Epitopes);突变(Mutation);受体, 抗原, T细胞(Receptors, Antigen, T-Cell);gag基因产物, 人免疫缺陷病毒(gag Gene Products, Human Immunodeficiency Virus)

DOI 10.3389/fimmu.2022.822210

PMID 35173732

发布时间 2022-03-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in immunology

2022年13卷

822210页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Structural Basis for Unusual TCR CDR3β Usage Against an Immunodominant HIV-1 Gag Protein Peptide Restricted to an HLA-B*81:01 Molecule.

Frontiers in immunology

相似文献

Frontiers in immunology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Structural Basis for Unusual TCR CDR3β Usage Against an Immunodominant HIV-1 Gag Protein Peptide Restricted to an HLA-B*81:01 Molecule.

Frontiers in immunology

相似文献

Frontiers in immunology

相关期刊

检索历史清除